Advertisement

Reactions Weekly

, Volume 1723, Issue 1, pp 291–291 | Cite as

Vedolizumab

Severe general systemic allergic reaction with dyspnoea following off label use: case report
Case report

Reference

  1. Schneider A-M, et al. Vedolizumab use after failure of TNF-alpha antagonists in children and adolescents with inflammatory bowel disease. BMC Gastroenterology 18: 140, No. 1, 15 Sep 2018. Available from: URL: http://doi.org/10.1186/s12876-018-0868-x - Austria

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations